1.36
Mira Pharmaceuticals Inc Aktie (MIRA) Neueste Nachrichten
Is MIRA Pharmaceuticals Inc. a candidate for recovery play2025 Breakouts & Breakdowns & Fast Entry and Exit Trade Plans - newser.com
MIRA Pharmaceuticals Completes SKNY Acquisition - TipRanks
MIRA Pharmaceuticals Closes Acquisition of SKNY Pharmaceuticals - citybiz
MIRA Pharmaceuticals completes acquisition of SKNY Pharmaceuticals By Investing.com - Investing.com South Africa
MIRA Pharmaceuticals Closes Acquisition of SKNY Pharmaceuticals, Expands Pipeline with SKNY-1 for Obesity and Nicotine Addiction - ACCESS Newswire
MIRA Pharmaceuticals completes acquisition of SKNY Pharmaceuticals - Investing.com India
Mira Pharmaceuticals completes acquisition of SKNY Pharmaceuticals By Investing.com - Investing.com South Africa
30% Weight Loss: MIRA Pharma Acquires Novel Obesity Drug SKNY-1 That Also Treats Nicotine Addiction - Stock Titan
Mira Pharmaceuticals completes acquisition of SKNY Pharmaceuticals - Investing.com
What data driven models say about MIRA Pharmaceuticals Inc.’s futureJuly 2025 Sentiment & Free Risk Controlled Daily Trade Plans - newser.com
Can MIRA Pharmaceuticals Inc. stock surprise with earnings upside2025 Analyst Calls & Fast Moving Market Watchlists - newser.com
MIRA Pharmaceuticals (NASDAQ:MIRA) Advances Neuroscience Research - Kalkine Media
Is MIRA Pharmaceuticals Inc. stock a buy in volatile marketsWatch List & Safe Capital Investment Plans - newser.com
How to interpret RSI for MIRA Pharmaceuticals Inc. stockTrade Ideas & Risk Managed Investment Entry Signals - newser.com
What moving averages say about MIRA Pharmaceuticals Inc.Weekly Investment Recap & Technical Pattern Based Signals - newser.com
Using fundamentals and technicals on MIRA Pharmaceuticals Inc.2025 Institutional Moves & Community Consensus Picks - newser.com
MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study - The Augusta Chronicle
What indicators show strength in MIRA Pharmaceuticals Inc.2025 Geopolitical Influence & Consistent Profit Trading Strategies - newser.com
MIRA Pharmaceuticals Announces FDA Clearance of IND for Ketamir-2, Enabling U.S. Clinical Trials in Neuropathic Pain - The Daily Jeffersonian
Custom strategy builders for tracking MIRA Pharmaceuticals Inc.Trade Volume Report & Daily Market Momentum Tracking - newser.com
What drives MIRA Pharmaceuticals Inc stock priceStraddle and Strangle Trades & Small Entry Cost Investments - earlytimes.in
MIRA Pharmaceuticals Shareholders Approve Acquisition of SKNY Pharmaceuticals, Advancing Next-Generation Oral Therapeutic for Obesity and Smoking Cessation - Sarasota Herald-Tribune
What analysts say about MIRA Pharmaceuticals Inc stockMarket Breadth Indicators & Buy Sell Timing Alerts - earlytimes.in
Is MIRA Pharmaceuticals Inc. stock overvalued by current metricsJuly 2025 Price Swings & Capital Protection Trading Alerts - newser.com
MIRA Pharmaceuticals Reports Positive PTSD Data Demonstrating Ketamir-2 Restores Normalized Behavior in Stressed Animals - Sarasota Herald-Tribune
Can MIRA Pharmaceuticals Inc. stock sustain free cash flow growthBear Alert & Momentum Based Trading Signals - newser.com
How MIRA Pharmaceuticals Inc. stock reacts to bond yieldsJuly 2025 Macro Moves & Safe Entry Trade Reports - The British Mountaineering Council
Analyzing MIRA Pharmaceuticals Inc. with multi timeframe chartsEarnings Trend Report & Growth Focused Stock Pick Reports - newser.com
MIRA Pharmaceuticals reports positive Phase 1 results for pain drug By Investing.com - Investing.com Nigeria
MIRA Pharmaceuticals reports positive Phase 1 results for pain drug - Investing.com India
Published on: 2025-09-22 12:43:38 - newser.com
MIRA Pharmaceuticals Reports Positive Phase 1 Study Results - TipRanks
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):